Predict your next investment

Corporation
HEALTHCARE | Medical Devices & Equipment
edwards.com

See what CB Insights has to offer

Investments

18

Portfolio Exits

2

Funds

1

Partners & Customers

5

About Edwards Lifesciences

Edwards Lifesciences (NYSE: EW) is a medical equipment and devices company that designs, manufactures, and markets tissue heart valves and related repair products. The company also provides solutions in enhanced surgical recovery, clot management, infection control, anesthesia, hospital administration, annuloplasty rings, catheters, hemodynamic monitoring, and more.

Edwards Lifesciences Headquarter Location

One Edwards Way

Irvine, California, 92614,

United States

949-250-2500

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Edwards Lifesciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Edwards Lifesciences in 3 Expert Collections, including Medical Devices.

M

Medical Devices

4,284 items

https://www.advamed.org/membership-join/membership-directory/ - excludes those without working websites.

H

Health Monitoring & Diagnostics

313 items

Companies developing technology for computer-aided diagnostic imaging. Companies tagged as #ComputerAidedDxImaging

H

Health IT

360 items

Edwards Lifesciences Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Edwards Lifesciences Rank

Latest Edwards Lifesciences News

EPA names BD, Edwards and Medtronic on list of higher-risk sterilization facilities

Aug 4, 2022

Published Aug. 4, 2022 Dive Brief: The Environmental Protection Agency has included facilities run by Becton Dickinson, Edwards Lifesciences and Medtronic on a list of sterilization sites that pose risks to nearby communities. The EPA found 23 commercial sterilization facilities that emit high levels of ethylene oxide (EtO), long-term exposure to which can increase the lifetime risk of getting cancer. Air pollution regulation intended to address EtO emissions is planned for later this year. Medtech trade group AdvaMed responded to the publication of the list, cautioning that EtO is vital for the prevention of serious infections and that the shutdown of facilities could disrupt the supply of medical devices. Dive Insight: The publication of the list is the culmination of years of focus on EtO emissions that has seen plants shut down over their environmental impact. Companies including Boston Scientific and Sterigenics began tracking their emissions under new EPA rules at the start of the year. Now, the EPA has used updated EtO emissions information from commercial sterilizers to estimate the increased risk of cancer. The analysis found elevated risks at or above 100 in a million in residential areas at 23 sterilizers. Four of the facilities, including those run by Edwards and Medtronic , are in Puerto Rico. The EPA mapped areas around the facilities in which there is an estimated lifetime cancer risk of 100 in a million or greater from breathing air containing EtO emitted from the plants. In small areas close to the facilities, the risks are higher, with the EPA putting the risk for some people near to the Edwards site at 5,000 in a million. Two of the facilities in the continental U.S., one in Nebraska and one in Utah , are run by BD. The other facilities are run by companies including International Sterilization Laboratory, Professional Contract Sterilization and Terumo BCT Sterilization Service. The EPA has plans to propose air pollution regulation later this year to address EtO emissions at commercial sterilizers. Ahead of the release of the regulation, AdvaMed has warned of the potential for actions against EtO emissions to cause unintended consequences that harm patients. “The shutdown of medical device sterilization facilities due to misinformed political pressure, as well as the uncertainty regarding which regulations the facilities must adhere to as EPA works to update the federal rule, would be disastrous to public health under the best of circumstances; it could be catastrophic, in light of the fragile global supply chain, which hospitals are already strained to address,” AdvaMed CEO Scott Whitaker said in a statement. The Food and Drug Administration, which is investigating alternative sterilization methods, responded to the EPA list, stating it “shares concerns about the release of ethylene oxide at unsafe levels into the environment” but “other methods of sterilization cannot currently replace the use of EtO for many devices.” The FDA is equally concerned about potential shortages of medical devices.

Edwards Lifesciences Investments

18 Investments

Edwards Lifesciences has made 18 investments. Their latest investment was in egnite as part of their Seed on February 2, 2021.

CBI Logo

Edwards Lifesciences Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/10/2021

Seed

egnite

Yes

2

9/23/2020

Series C - II

V-Wave

$28M

No

2

7/15/2020

Series B

Caption Health

$53M

Yes

5

4/26/2018

Series C

Subscribe to see more

$99M

Subscribe to see more

10

4/13/2016

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/10/2021

9/23/2020

7/15/2020

4/26/2018

4/13/2016

Round

Seed

Series C - II

Series B

Series C

Series A - II

Company

egnite

V-Wave

Caption Health

Subscribe to see more

Subscribe to see more

Amount

$28M

$53M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

2

5

10

10

Edwards Lifesciences Portfolio Exits

2 Portfolio Exits

Edwards Lifesciences has 2 portfolio exits. Their latest portfolio exit was Middle Peak Medical on February 14, 2017.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/14/2017

Acquired

$99M

1

9/21/2007

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

Date

2/14/2017

9/21/2007

Exit

Acquired

Acquired

Companies

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Subscribe to see more

Sources

1

0

Edwards Lifesciences Acquisitions

13 Acquisitions

Edwards Lifesciences acquired 13 companies. Their latest acquisition was Corvia Medical on March 11, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

3/11/2019

Series E+

$99M

$108.28M

Acquired

2

11/29/2018

$99M

Acquired Unit

1

11/26/2018

$99M

Acquired Unit

1

4/18/2018

Subscribe to see more

$99M

Subscribe to see more

10

12/6/2017

Series B

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

3/11/2019

11/29/2018

11/26/2018

4/18/2018

12/6/2017

Investment Stage

Series E+

Series B

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$108.28M

$99M

Note

Acquired

Acquired Unit

Acquired Unit

Subscribe to see more

Subscribe to see more

Sources

2

1

1

10

10

Edwards Lifesciences Fund History

1 Fund History

Edwards Lifesciences has 1 fund, including Social Impact Investment Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

8/2/2021

Social Impact Investment Fund

$70M

1

Closing Date

8/2/2021

Fund

Social Impact Investment Fund

Fund Type

Status

Amount

$70M

Sources

1

Edwards Lifesciences Partners & Customers

5 Partners and customers

Edwards Lifesciences has 5 strategic partners and customers. Edwards Lifesciences recently partnered with UPS on May 5, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

5/4/2020

Vendor

United States

UPS Supports Edwards Lifesciences' Distribution Of Critical ICU Monitoring Equipment And Other Medical Technologies

UPS - Get Report today announced as part of its longstanding relationship with Edwards Lifesciences , it continues to help the med-tech company get necessary equipment to hospitals around the world in the ongoing battle against COVID-19 .

3

12/10/2018

Partner

United States

Subscribe to see more

Subscribe to see more

10

6/29/2015

Vendor

United States

Subscribe to see more

Subscribe to see more

10

11/24/2004

Licensor

Netherlands

Subscribe to see more

Subscribe to see more

10

Licensor

United States

Subscribe to see more

Subscribe to see more

10

Date

5/4/2020

12/10/2018

6/29/2015

11/24/2004

Type

Vendor

Partner

Vendor

Licensor

Licensor

Business Partner

Country

United States

United States

United States

Netherlands

United States

News Snippet

UPS Supports Edwards Lifesciences' Distribution Of Critical ICU Monitoring Equipment And Other Medical Technologies

UPS - Get Report today announced as part of its longstanding relationship with Edwards Lifesciences , it continues to help the med-tech company get necessary equipment to hospitals around the world in the ongoing battle against COVID-19 .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

10

10

10

10

Edwards Lifesciences Team

14 Team Members

Edwards Lifesciences has 14 team members, including current Chief Executive Officer, Michael A. Mussallem.

Name

Work History

Title

Status

Michael A. Mussallem

Chief Executive Officer

Current

David Pyott

Chief Executive Officer

Current

Thomas M Abate

Chief Financial Officer

Current

Anita B. Bessler

Chief Financial Officer

Current

Arie Rand

Delta Three, Top Image Systems, and Delta Galil Industries

Chief Financial Officer

Current

Name

Michael A. Mussallem

David Pyott

Thomas M Abate

Anita B. Bessler

Arie Rand

Work History

Delta Three, Top Image Systems, and Delta Galil Industries

Title

Chief Executive Officer

Chief Executive Officer

Chief Financial Officer

Chief Financial Officer

Chief Financial Officer

Status

Current

Current

Current

Current

Current

You May Also Like

Sensome Logo
Sensome

Sensome develops micro-sensor technology for smart medical devices. Sensome's sensing technology can be integrated with any medical device to reliably identify biological tissues in contact with the device. The technology combines micrometric impedance sensors that communicate wirelessly outside the body and machine learning algorithms for accurate and predictive real-time analysis.

Bigfoot Biomedical Logo
Bigfoot Biomedical

Bigfoot Biomedical is on a mission to improve the lives of people with insulin-requiring diabetes through the application of smart technology. Bigfoot's approach includes delivering an Internet-of-Things medical device, a cloud-connected system bundled as a monthly subscription service, to a broad population historically challenged by the high upfront costs of traditional insulin delivery hardware.

Implandata Ophthalmic Products Logo
Implandata Ophthalmic Products

Implandata Ophthalmic Products offers the EYEMATE system to empower people to take control of glaucoma – anytime and anywhere. EYEMATE is an AI-powered, cloud-based, data-centric platform for 24/7/365 monitoring and predictive modeling of disease progression. EYEMATE's data analytics combine IOP with other vital parameters to enable personalized therapies. For people with glaucoma, this means improved quality of life and peace of mind. For eye doctors, this means improved patient care at a significantly lower cost.

CeQur Logo
CeQur

CeQur is developing and commercializing advanced yet simple-to-use insulin delivery devices that make it easier for people living with type 2 diabetes to adhere to therapy and stay in control of their disease. The Company's fully optimized device, PaQ, is a three-day, wearable device that provides freedom from multiple daily insulin injections.

Nonin Medical Logo
Nonin Medical

Nonin Medical is a medical device company. It had developed the Pulse Oximeter. Nonin Medical offers non-invasive patient monitoring systems including fingertip and tabletop pulse oximeters, regional oximetry, capnography, near-infrared spectroscopy and BIS monitors.

Withings Logo
Withings

Withings creates smart products and apps to help people across the world take care of their health and well-being. By extending the capabilities of an object through network resources, Withings provides access to computing and storage facility at no extra cost, turning objects into smart connected devices.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.